BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6841559)

  • 1. Primary cortisol resistance: a family study.
    Chrousos GP; Vingerhoeds AC; Loriaux DL; Lipsett MB
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1243-5. PubMed ID: 6841559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cortisol resistance: a familial syndrome and an animal model.
    Chrousos GP; Loriaux DL; Brandon D; Tomita M; Vingerhoeds AC; Merriam GR; Johnson EO; Lipsett MB
    J Steroid Biochem; 1983 Jul; 19(1B):567-75. PubMed ID: 6887885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol resistance in man.
    Lipsett MB; Tomita M; Brandon DD; De Vroede MM; Loriaux DL; Chrousos GP
    Adv Exp Med Biol; 1986; 196():97-109. PubMed ID: 3012986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease.
    Chrousos GP; Vingerhoeds A; Brandon D; Eil C; Pugeat M; DeVroede M; Loriaux DL; Lipsett MB
    J Clin Invest; 1982 Jun; 69(6):1261-9. PubMed ID: 6282933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial cortisol resistance: differential diagnostic and therapeutic aspects.
    Lamberts SW; Poldermans D; Zweens M; de Jong FH
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1328-33. PubMed ID: 3782421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cortisol resistance accompanied by a reduction in glucocorticoid receptors in two members of the same family.
    Iida S; Gomi M; Moriwaki K; Itoh Y; Hirobe K; Matsuzawa Y; Katagiri S; Yonezawa T; Tarui S
    J Clin Endocrinol Metab; 1985 May; 60(5):967-71. PubMed ID: 3980675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the integrated 3-hour plasma cortisol concentration as a test for Cushing's syndrome.
    Desai RK; Jialal I; Naidoo C; Omar MA; Joubert SM
    S Afr Med J; 1987 Feb; 71(3):156-7. PubMed ID: 3810361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
    Findling JW; Raff H; Aron DC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y; Allali-Zerah V; Chayvialle JA; Leroyer R; Leymarie P; Travert G; Lebrethon MC; Budi I; Balliere AM; Mahoudeau J
    N Engl J Med; 1992 Oct; 327(14):981-6. PubMed ID: 1325609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolism.
    Halbreich U; Zumoff B; Kream J; Fukushima DK
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1262-4. PubMed ID: 7200488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid resistance in humans and nonhuman primates.
    Brandon DD; Markwick AJ; Chrousos GP; Loriaux DL
    Cancer Res; 1989 Apr; 49(8 Suppl):2203s-2213s. PubMed ID: 2649236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
    Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of free cortisol in urine (author's transl)].
    Deck KA; Eberlein L; Vetter H; Hillen H
    Dtsch Med Wochenschr; 1976 May; 101(21):818-21. PubMed ID: 178496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
    Kaplan AJ; Peterson ME; Kemppainen RJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):445-51. PubMed ID: 7591942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.